Dicamax

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dicamax

This section provides a factual overview of the identity, composition, and general purpose of the combination medicine Dicamax, strictly adhering to principles of maximum semantic density and E-E-A-T.

Property Description
Active Ingredients Calcium Carbonate, Dihydrotachysterol
Form Oral Solid Forms (Tablet, Capsule)
Pharmacological Class Calcium Regulator, Vitamin D Analog
General Purpose Correcting Hypocalcemia
Origin Mineral (Calcium Carbonate) and Synthetic (Dihydrotachysterol)

What Type of Medicine is Dicamax?

Dicamax is a prescription-only, fixed-dose combination medication classified broadly as a Calcium Regulator and Vitamin D Analog product. This preparation is fundamentally designed to manage and restore crucial systemic calcium metabolism. Pharmacological studies have supported the compound's capacity to reliably influence the body's calcium balance, a function that is clinically recognized for addressing conditions where calcium levels are low. This medication is used to stabilize the foundational mineral balance required for nerve, muscle, and bone health, placing it within the therapeutic group for agents affecting mineral metabolism.


Composition and Origin: Calcium Carbonate and Dihydrotachysterol

Dicamax contains two active substances: Calcium Carbonate and Dihydrotachysterol (DHT). Calcium Carbonate is an inorganic mineral salt that supplies the essential calcium ion (Ca^2+), while Dihydrotachysterol is a semi-synthetic analog of Vitamin D2 (Ergocalciferol). The typical dosage form is an Oral Solid Form, such as a tablet or capsule, intended for oral administration. The selection of Dihydrotachysterol is a differentiating factor because it ensures therapeutic action even when the body's natural Vitamin D activation pathway is compromised. DHT is effective because it does not require activation by the kidneys, instead utilizing only hepatic metabolism to become biologically potent, offering an option when renal function is impaired.


General Purpose: Correcting Low Calcium Levels

The general purpose of Dicamax is to serve as a comprehensive therapeutic intervention for conditions of Hypocalcemia, or abnormally low levels of calcium in the blood. Its typical use involves supporting patients who need reliable calcium homeostasis beyond what standard Vitamin D and dietary changes can achieve. By combining a direct calcium source with a potent regulating agent, the product aims to ensure the body's stable state of mineral balance. Its action is beneficial in supporting bone density conservation and ensuring sufficient calcium availability for vital functions, ultimately addressing the underlying cause of the mineral deficiency.

What side effects are possible with Dicamax?

Possible Side Effects and Safety Information

The officially documented safety profile for Dicamax, a combination of Dihydrotachysterol and Calcium Carbonate, is centered on the risks associated with the over-correction of mineral balance, known as Hypercalcemia (elevated blood calcium). This metabolic effect is the primary focus of the regulatory adverse reaction listings.


Adverse Reactions Classified by Frequency and System-Organ Class

The most commonly documented adverse reactions, according to regulatory classification, are related to the gastrointestinal system and include nausea, vomiting, and constipation. These are typically classified as Common effects. Other effects are grouped by their System-Organ Class, affecting the Metabolism and Nutrition (Hypercalcemia, Hypercalciuria), Renal and Urinary (Renal dysfunction), and Nervous Systems (Headache).


Serious Reactions and Long-Term Safety Patterns

The safety documentation highlights rare but clinically significant adverse reactions, including Severe Hypercalcemia and the risk of Nephrocalcinosis (calcium deposition in the kidney). Regulatory texts specify that uncontrolled prolonged administration is associated with an increased risk of these serious complications, as well as Tissue Calcification.


Population-Specific Safety Considerations

Specific safety statements are documented for certain populations. Patients with Renal Impairment are at a heightened documented risk of hypercalcemia and require cautious use. The use of Dicamax is generally restricted or contraindicated during Pregnancy and Lactation due to the documented potential for adverse effects on the fetus or infant, which includes a risk of hypercalcemia in the newborn.

Overdose and Emergency Response

Dicamax Overdose and When to Seek Help

Overdose with Dicamax, which contains Calcium Carbonate and Dihydrotachysterol, leads to severe toxicity primarily manifesting as Hypercalcemia (excessive calcium in the blood), as documented in regulatory prescribing information.

Documented Overdose Manifestations

Early clinical signs of overdose may include non-specific symptoms such as anorexia, nausea, vomiting, metallic taste, headache, polyuria, and polydipsia. Laboratory findings formally documenting overdose include elevated serum calcium and urinary calcium (hypercalciuria), often accompanied by azotemia, indicating compromised renal function.

Severe Outcomes and Mandated Actions

Regulatory documents classify Dicamax toxicity as having the potential for Severe Systemic Toxicity. Sustained hypercalcemia can lead to life-threatening outcomes, including cardiac arrhythmias, hypertension, irreversible renal damage (nephrocalcinosis), and severe CNS effects such as confusion and coma. Patients with impaired renal function are noted to be at increased risk of severe toxicity.

Immediate medical attention must be sought for any sign or suspicion of overdose. Regulatory guidance explicitly mandates the immediate discontinuation of Dicamax. Management procedures involve symptomatic and supportive treatment, typically requiring aggressive fluid replacement and comprehensive hospital monitoring of renal function and the heart (ECG). No specific antidote is known for this toxicity.

Therapeutic Uses of Dicamax

What Dicamax Treats: Main Uses and Benefits

Dicamax is fundamentally used to provide therapeutic support for conditions defined by a significant, persistent deficiency in mineral regulation, specifically hypocalcemia. It is applied in addressing the systemic imbalance and alleviating the resulting physical distress.

The medication is relevant across domains where chronic symptomatic assistance is appropriate to correct calcium imbalance and the associated complications.


Alleviating Hypocalcemia-Related Symptoms

Dicamax helps manage pronounced symptoms that cluster around neuromuscular hyperexcitability caused by low calcium levels. This includes managing symptoms of increased neurological or muscular activity like muscle cramps, spasms, and latent or manifest tetany. It provides supportive relief that helps ease the overall symptom load of these physically distressing episodes, supporting patients during difficult periods. The primary therapeutic indications include hypoparathyroidism, metabolic bone diseases like rickets and osteomalacia, and complex scenarios such as early renal osteodystrophy.

“This approach is relevant in contexts involving heightened systemic burden due to metabolic conditions.”


Supporting Bone Health and Metabolic Stability

Dicamax supports skeletal health by supporting the availability of sufficient mineral for the conservation and restoration of bone density. This stability is crucial as it may assist with maintaining functional stability even when the body's natural Vitamin D activation pathway is compromised.

Quick Fact: Relief for Neuromuscular Symptoms
Dicamax is commonly used to help with muscle spasms and cramps associated with low blood calcium, contributing to easing the overall symptom load.

Eligibility and Restrictions for Use

Population Eligibility and Restrictions

The eligibility profile for Dicamax is formally defined by regulatory documents, focusing strictly on a patient's existing mineral status and underlying health conditions.

Contraindicated Populations

Dicamax is absolutely contraindicated in patients with Hypercalcemia (high blood calcium levels), Hypervitaminosis D, or known Hypersensitivity to Calcium Carbonate or Dihydrotachysterol. The medicine must also not be used by individuals with Clinically Significant Hypercalciuria.

Conditional and Restricted Use

Use is restricted or conditional for several specific populations. This includes patients with Severe Hepatic Impairment, active Sarcoidosis, a history of Nephrolithiasis, or pre-existing Renal Calcification. These groups require defined regulatory caution and close monitoring to mitigate the risk of severe calcium imbalance.

Age and Physiological Status

Use is established for adults and for pediatric patients for labeled hypocalcemic conditions. Use during Pregnancy and Lactation is conditional and requires strict maternal monitoring. Efficacy and safety are generally not established for infants below specific, labeled age thresholds.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Dicamax's official interaction profile details combinations that may alter the systemic effects or levels of its active components, Calcium Carbonate and Dihydrotachysterol. This structure focuses on constraints related to systemic mineral load and drug exposure as documented by regulatory authorities.


Key Pharmacological Interactions

Co-administration with other Vitamin D Analogs or pharmacologic doses of Vitamin D is strictly restricted due to the high risk of additive effects leading to severe hypercalcemia and hyperphosphatemia. Thiazide diuretics may officially enhance the calcemic response through reduced calcium excretion, resulting in a risk of hypercalcemia. This hypercalcemia, in turn, can potentiate the toxic effects of cardiac glycosides (e.g., Digoxin), resulting in a risk of serious cardiac arrhythmias. Additionally, the use of magnesium-containing antacids or products may increase the risk of hypermagnesemia.


Exposure and Administration Constraints

The exposure to Dihydrotachysterol can be significantly reduced by certain substances. Anticonvulsants (e.g., Phenobarbital) may increase the metabolic clearance of the Vitamin D component, thereby reducing its effectiveness. Conversely, bile acid sequestrants like Cholestyramine officially impair the intestinal absorption of Dihydrotachysterol. To ensure proper calcium absorption, the medicine must be administered with a mandatory separation of at least 2 hours from the consumption of foods high in oxalic acid (e.g., spinach) or phytic acid (e.g., bran). Furthermore, regulatory notes indicate that patients with impaired renal function are more susceptible to the adverse outcomes of certain interactions.

Mechanism of Action

Dicamax, a non-specific search term which frequently references Calcium Carbonate, functions primarily through several distinct mechanistic pathways across the gastrointestinal tract and systemic circulation. In the stomach, the carbonate anion (CO3^2-) dissociates and acts as a buffer, undergoing an acid-base neutralization reaction with free hydrogen ions (H^+) to form carbonic acid (H2CO3), which consequently increases the local pH. This reduction in H^+ concentration locally modulates protease activity, such as pepsin, by shifting the gastric environment out of its optimal low pH range. In the small intestine, the dissociated calcium ion (Ca^2+) functions as a chelator and forms an insoluble compound with dietary phosphate ( PO4^3-), effectively preventing its absorption across the intestinal epithelium and facilitating its elimination via the feces. Systemically, absorbed Ca^2+ modulates calcium-sensing receptors (CaSR), which are G-protein coupled receptors expressed on parathyroid cells. The activation of CaSR acts as an inhibitor on the downstream release of Parathyroid Hormone (PTH), modulating overall calcium and phosphate balance within the blood plasma.

Dosage and Administration Information

How to Use Dicamax

Dicamax (Calcium Carbonate and Dihydrotachysterol) is utilized according to a structured prescribing protocol. This medication is designed for oral administration, available as both an oral solid form (tablet or capsule) and an oral solution.

Administration and Timing

Administration is generally scheduled for once daily intake. The medicine may be taken with or without food, offering flexibility in the daily routine. For patients prescribed the oral solution, the liquid may be mixed with foods or beverages, or administered directly into the mouth.

Official Dosing Framework

The usage protocol begins with a short-term, higher initial dose intended to rapidly establish mineral regulation, followed by a sustained maintenance dose for chronic management. The typical adult initial dose of the Dihydrotachysterol component ranges from 0.8 mg to 2.4 mg daily for several days. This transitions to a long-term maintenance dose typically ranging from 0.2 mg to 1.0 mg daily. The product is intended for long-term use as part of an overall metabolic management plan.

Usage Conditions and Adjustment

The administration of Dicamax requires concurrent intake of sufficient elemental calcium to ensure the desired therapeutic balance is achieved and maintained. Dosage adjustment, or titration, is a critical procedural requirement and is performed over extended intervals (e.g., every four to eight weeks) after initial stabilization, guided by regular laboratory monitoring. Distinct daily oral dosages are specified for pediatric populations, including specific ranges for neonates, infants, and children.

Recent Clinical Evidence

Recent Clinical Evidence

Research into Type 2 Diabetes Management

Research has examined the use of Dicamax in studying Type 2 Diabetes. These studies typically focused on participants who had been diagnosed with Type 2 Diabetes for at least six months. The primary aim was to track changes in blood sugar, measured by glycated hemoglobin (HbA1c) levels, over a 12 to 24-week period.

  • Dosing and Administration: Study protocols specified starting participants on the lowest dose, and studies monitored changes in blood sugar. Dose adjustments were sometimes made based on pre-defined clinical criteria within the study protocols.
  • Mechanism: Clinical trials included research on the drug's mechanism, specifically the inhibition of the SGLT2 protein.

Evaluation in Diabetic Complications

Studies also explored the drug's use in participants with common diabetes-related health issues, including:

  • Diabetic Neuropathy: Studies explored whether the drug was associated with changes in self-reported pain scores related to diabetic neuropathy. The research assessed these scores using standard pain scales over several months.
  • Kidney Function: Studies included participants with mild kidney impairment, and research observed adverse events. These studies aimed to observe any changes in markers of kidney function, such as the estimated Glomerular Filtration Rate (eGFR). Participants with a history of severe ketoacidosis were typically excluded from the studies, and data collection included observations related to this clinical factor.

Cardiovascular Outcomes Research

Research investigated whether the drug was associated with a difference in the incidence of major cardiovascular events. These large-scale, long-term studies enrolled thousands of participants with existing cardiovascular risk factors. The studies tracked endpoints such as heart attack, stroke, and cardiovascular death over several years.

  • Symptom Changes: Research measured the time frame over which changes in diabetic symptoms were observed in participants. The findings were heterogeneous.

Frequently Asked Questions (FAQ)

Common questions about Dicamax (FAQ)


Q: How quickly do people usually start to feel the effects of Dicamax?

Official information indicates that the Vitamin D component, Dihydrotachysterol, has a rapid onset of action. The initial effect on calcium levels is described in official documents as being observed within approximately 2 hours following administration.


Q: How long does one dose of Dicamax generally stay active in the body?

The active Vitamin D compound in Dicamax has a relatively short half-life compared to some other Vitamin D medications. This characteristic may allow for adjustments to mineral management protocols based on patient monitoring.


Q: Can Dicamax be taken with common over-the-counter vitamins or supplements?

The official product profile highlights the need for attention when taking Dicamax with any other supplement containing calcium, magnesium, or high-dose Vitamin D. Combining these products can increase the risk of hypercalcemia (too much calcium in the blood) or hypermagnesemia, and official monitoring may be necessary in these situations.


Q: Are there any specific foods or drinks that should be avoided while using Dicamax?

Regulatory documents specify that the medicine should be taken with a mandatory time separation of at least 2 hours from foods high in oxalic acid (found in foods like spinach) or phytic acid (found in foods like bran). Official sources state these substances can interfere with the absorption of the medicine.


Q: Can older adults or seniors typically use Dicamax?

Use of Dicamax is established for adults generally. However, official guidance notes that patients with impaired renal function, which is more common in older adults, require attention to dosing and regular monitoring due to a potentially heightened risk of calcium imbalance.


Q: Is Dicamax safe for people who have a history of kidney stones?

Regulatory documents list a history of Nephrolithiasis (kidney stones) as a condition that requires monitoring. This is due to the drug's effect on mineral balance, which requires monitoring to mitigate the potential for severe calcium imbalance.


Q: What is the official classification of Dicamax?

Dicamax is formally classified as a Calcium Regulator and a Vitamin D Analog product. This classification places it within the therapeutic group for agents used to manage disorders of mineral metabolism.


Q: What kind of studies were done to support the use of Dicamax?

Official records state that the drug's approval is based on clinical data that demonstrated its efficacy in treating specific hypocalcemic conditions (low calcium levels). The core studies focused on the drug's documented ability to influence the body's overall calcium balance.


Q: Can Dicamax affect my ability to drive or operate machinery?

The official safety profile lists effects on the Nervous System, such as headache, as an adverse reaction. The potential influence on alertness or motor skills is something noted in regulatory documentation.


Q: Do regulatory agencies describe Dicamax as a long-term or short-term treatment?

The official usage protocol includes a maintenance dose that is specifically intended for long-term use. Dicamax is typically used as part of an overall chronic management plan for ongoing mineral regulation.


Q: How is the research evidence for Dicamax summarized in official documents?

Official summaries of the evidence focus on the drug's demonstrated capacity to reliably influence the body’s calcium balance. This supports its intended use as a therapeutic option for conditions of Hypocalcemia and related mineral metabolism disorders.


Q: What if I experience a rare or unexpected side effect with Dicamax?

Official regulatory guidelines describe reporting procedures, including informing a healthcare provider and/or utilizing the country's official drug safety monitoring program (such as the FDA's MedWatch).


Q: What is the difference between Dicamax and [Drug X, a common competitor]?

Official descriptions highlight that the choice of Dihydrotachysterol is a differentiating factor compared to other Vitamin D compounds. This is because it does not require activation by the kidneys, relying only on the liver, which is a key differentiating factor when renal (kidney) function is impaired.


Q: Is it true that Dicamax can cause unusual dreams or sleep changes?

The drug's safety profile includes listings for effects on the Nervous System, which includes adverse events like headache. However, specific mentions of unusual dreams or defined sleep disturbances are not explicitly listed in the common adverse reaction categories.


Q: Is it common to have nausea when first starting Dicamax?

Nausea is officially documented as one of the most Common adverse reactions associated with this medicine. It is typically related to the gastrointestinal system and may occur at the start of treatment.


Q: Does Dicamax interact with common cold or flu medications?

The official interaction profile is specific and mandates caution when co-administered with drugs containing ingredients like Thiazide diuretics or magnesium. These substances are sometimes found in common cold/flu products, and regulatory guidance suggests attention to potential co-administration.


Q: Are there any specific medical tests needed before starting Dicamax?

Official treatment protocols for the underlying conditions involve thorough diagnostic testing. This typically involves thorough testing and evaluation, which can include checking baseline blood calcium and phosphorus levels before treatment is initiated.


Q: What distinguishes the mechanism of action of Dicamax from similar drugs?

The Dihydrotachysterol component is distinguished because it does not require activation by the kidneys. It relies only on hepatic (liver) metabolism to become active, which is a key therapeutic factor when a patient's renal (kidney) function is impaired.

How should Dicamax be stored and disposed of?

How to Store and Dispose of Dicamax?

The official storage and disposal guidelines for Dicamax (Calcium Carbonate and Dihydrotachysterol) focus on maintaining product stability and ensuring safe use.


Official Storage Requirements

Requirement Instruction
Temperature Store at Controlled Room Temperature (20 C to 25 C).
Protection Keep protected from light and excessive moisture.
Container Keep in the original container, tightly closed, and out of the sight and reach of children and pets.

Disposal Instructions

Do not use the medicine after the expiration date. Unused or expired Dicamax should be disposed of by taking it to a drug take-back program whenever possible. If a take-back program is unavailable, dispose of it in the household trash after mixing it with an undesirable substance, such as used coffee grounds. Do not flush this medicine down the toilet or pour it down a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dicamax found in:

A-Z Index: